Skip to main content

Ongoing FDAEvent 98942 (3 months ago)

PFM Medical Multi-Snare Sets

The Multi-Snare Set failed to meet biocompatibility requirements, which could cause localized inflammation and tissue irritation.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

PFM Medical Inc. of Carlsbad, California, began a recall on April 21, 2026, for the Multi-Snare Set: 5 mm x 125 cm, REF: 147305, and the 10 mm x 125 cm, REF: 147310.

The snare catheter, indicated for removal or manipulation of a foreign body in the vascular system, failed to meet the biocompatibility requirements for in-vitro-cytotoxicity, which could result in localized inflammation and tissue irritation if in contact with a patient's vasculature.

The FDA added the recall to its Enforcement Report and classified it on June 23, 2026, with distribution in New York and Maryland.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is your set affected?

Affected if its UDI-DI and lot code are listed under that product.

  1. Multi-Snare Set: 5 mm x 125 cm, REF: 147305; 10 mm x 125 cm, REF: 147310

    UDI-DI
    • 04042301061829
    • 04042301033567
    Lot
    • 147305
    • 1049868

Details

Company began the recall
Sold in

US Nationwide distribution in the states of New York, Maryland.

Event ID
98942
Recall No.
Z-2526-2026
Company
PFM MEDICAL INC.Carlsbad, California
Recall type
Voluntary: Firm initiated
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration